Administration mode matters for 5-fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus.

Saved in:
Bibliographic Details
Title: Administration mode matters for 5-fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus.
Authors: Chao CJ; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan., Gardner I; Simcyp Division, Certara UK Limited, Sheffield, UK., Lin CJ; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan., Yeh KH; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Lu WC; Department of Pharmacy, MacKay Memorial Hospital, Taipei, Taiwan., Abduljalil K; Simcyp Division, Certara UK Limited, Sheffield, UK., Ho YF; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.; Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Apr; Vol. 91 (4), pp. 1031-1040. Date of Electronic Publication: 2024 Apr 16.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2125
DOI:10.1111/bcp.16061